Table 3.

Aspirin versus control outcomes

		Aspirin (n=1945)	Control (n=1936)	HR (95% CI)	p value
Major thrombosis, hospitalisation, or death*		59 (3·0%)	73 (3·8%)	0·80 (0·57–1·13)	0·21
	Any thrombosis†‡	2 (0·1%)	5 (0·3%)	0·40 (0·08–2·06)	0·27
Any thrombosis, hospitalisation, or respiratory death		59 (3·0%)	73 (3·8%)	0·80 (0·57–1·13)	0·21
	Major thrombosis§	1 (0·1%)	4 (0·2%)	0·25 (0·03–2·23)	0·21
	Any venous thromboembolism	1 (0·1%)	4 (0·2%)	0·25 (0·03–2·24)	0·22
	Death	12 (0·6%)	11 (0·6%)	1·09 (0·48–2·46)	0·84
	Respiratory death	10 (0·5%)	7 (0·4%)	1·42 (0·54–3·73)	0·48
	Hospitalisation	56 (2·9%)	67 (3·5%)	0·83 (0·58–1·19)	0·31

Data are n (%) unless stated otherwise.

^*Primary outcome.

^†Includes stroke, myocardial infarction, acute limb ischaemia, and pulmonary embolism.

^‡Secondary outcome.

^§Includes major thrombosis plus deep vein thrombosis.